• This electron micrograph shows an oral squamous cancer cell being attacked by two cytotoxic T cells.

    This electron micrograph shows an oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red). The tumor-specific T cells were developed from the patient’s own immune system, a “personalized cancer vaccine” like those that may be developed in the future with the help of NIST’s standardized human genomes.Credit:R.E. Serda/National Cancer Institute and Duncan Comprehensive Cancer Center at Baylor College of Medicine


    September 2016

    GAITHERSBURG, Md.—With the addition of four new reference materials (RMs) to a growing collection of “measuring sticks” for gene sequencing, the National Institute of Standards and Technology (NIST) can now provide laboratories with even more capability to accurately “map” DNA for genetic testing, medical diagnoses and future customized drug therapies. The new tools feature sequenced genes from individuals in two genetically diverse groups, Asians and Ashkenazic Jews; a father-mother-child trio set from Ashkenazic Jews; and four microbes commonly used in research.

    NIST issued the world’s first genome reference material (NIST RM 8398)—detailing the genetic makeup for a woman with European ancestry—in May 2015. Together, all five RMs serve as a collection of well-characterized, whole genome standards that can tell a laboratory how well its DNA sequencing processes are working by measuring the performance of the equipment, chemistry and data analysis involved.

    The latest reference materials are:

    • NIST RM 8391—male of Eastern European Ashkenazic Jewish ancestry
    • NIST RM 8392—male son, father and mother who are a family of Eastern European Ashkenazic Jewish ancestry (with the son’s genome being the same released as NIST RM 8391)
    • NIST RM 8393—male of East Asian (Chinese) ancestry
    • NIST RM 8375—genomes for four bacterial species: Salmonella typhimurium LT2, Staphylococcus aureus, Pseudomonas aeruginosa and Clostridium sporogenes

    The individual human RMs provide a baseline for comparing and contrasting genes from distinctly different lineages while the Ashkenazic trio set aids the analysis of genetic links between family members. The bacterial genomes come from species that challenge the technical performance of sequencing methods and have been determined by the Food and Drug Administration(link is external) (FDA) to have significant relevance to the research of public health issues such as food contamination, antibiotic resistance and hospital-acquired infections.

    The three individual and one family set of standardized human genomes were created by NIST and its partners in the Genome in a Bottle consortium(link is external), a group that includes members from the federal government, academia and industry. The consortium is managed by the Joint Initiative for Metrology in Biology(link is external) (JIMB), a collaboration between NIST and Stanford University. Through its effort to develop, produce and distribute a suite of genome RMs, the consortium is providing medical and research laboratories worldwide with the tools they need to advance clinical applications of whole genome sequencing, and the FDA with the ability to conduct science-based regulatory oversight of the technology.


    Reference materials are critical to properly evaluate the next-generation of gene sequencing and genetic testing methods that will increase the reliability and effectiveness of precision medicine (also known as “personalized medicine”), in which a person’s genetic profile is used to create treatments and therapies unique to that individual.

    Sequencing devices take long strings of a person’s DNA and randomly chop them into small pieces that can be individually analyzed to determine their sequence of letters from the genetic code (A, C, G and T representing the four key components of DNA that code for protein production in living organisms: adenine, cytosine, guanine and thymine). The sequenced pieces can then be compared to a well-defined “reference sequence” to identify differences between the two codes. The differences reveal where mutations may have occurred in specific genes.

    However, biases and “blind spots” for certain sequences contribute to uncertainties or errors in the sequence analysis. These biases can lead to hundreds of thousands of disagreements between different sequencing results for the same human genome.

    To better understand these biases, laboratories can now compare their DNA sequences to those obtained from the DNA in any or all of the human genome RMs. The reference materials have been extensively characterized with multiple techniques, with the results weighted and analyzed to eliminate as much bias and error as possible.

    The new NIST human genome RMs increase the ability of DNA sequencing laboratories to be more confident in their reporting of true positives, false positives, true negatives and false negatives, and therefore, significantly improve genetic tests used for disease risk prediction, diagnosis, and progression tracking. They also can be used with tools developed by the Global Alliance for Genomics and Health Benchmarking Team(link is external) to further raise that confidence level.

    Similarly, the standardized microbial genomes in NIST RM 8375 can be used to assess the performance of high-throughput methods for microbial DNA sequencing.

    All five of the NIST reference materials are available for purchase from the NIST Standard Reference Material program. Each RM sample is characterized for homogeneity (ensuring that each vial contains similar DNA) and stability (ensuring that the DNA ordered now will be comparable to samples ordered in the future). The original sources for the RMs are from the Personal Genome Project(link is external), whose cell lines are hosted at the Coriell Institute for Medical Research(link is external).

    Future additions to the RM collection may include whole genomes from persons with Hispanic, African and mixed ancestries, as well as a set containing sequenced genes of both malignant tumor and normal cells from the same individual.

    As a non-regulatory agency of the Commerce Department, NIST promotes U.S. innovation and industrial competitiveness by advancing measurement science, standards and technology in ways that enhance economic security and improve our quality of life. For more information, visitwww.nist.gov.

    Bioscience, Genomic measurements, Health and Precision medicine


    2271 entityreference” href=”https://www.nist.gov/news-events/news/2015/05/measuring-stick-standard-gene-sequencing-now-available-nist”>’Measuring Stick’ Standard for Gene Sequencing Now Available from NIST



    No comments

    Be the first one to leave a comment.

    Post a Comment



    Latest Posts

    Latest Video



    FDA-approved study uses adipose stem cells for treatment of shoulder injuries

    SOURCE Sanford Health is conducting the first clinical trial approved by the FDA to treat injured shoulders using patients’ adipose…

    Could Anatomics BioModel Stereotaxy replace navigation or a robot?

    SOURCE Paul S D’Urso Neurosurgeon & Founder of Anatomics Because 3D printing is so accurate I was able to locate…

    $250 million awarded to new Advanced Robotics Manufacturing Innovation Hub

    SOURCE Headquartered in Pittsburgh, PA, the new institute is made up of governments, industry, academia, and non-profit organizations from across the country….

    Self-assembling 3D printing inks produce more true-to-life tissue

    SOURCE Biological and chemical researchers are developing 3D printable inks capable of self-assembly, i.e. forming a shape based on a…

    Urine Exosomes – An Emerging Trove of Biomarkers

     SOURCE Exosomes are released by most cells and can be isolated from all biofluids including urine. Exosomes are small vesicles…

    What is machine learning?

    SOURCE In this fascinating animation from Oxford Sparks, we take a look at how statistics and computer science can be used to…

    Catalia Health uses social robots to improve health outcomes

    Credit: Catalia Health SOURCE Catalia Health is leading the surge in social robotics, with Mabu, their patient care management system. Catalia…

    Ambry Genetics’ Big Data Sharing Program Now Available for Public Download

    SOURCE (So, WHY is this important?  Sounds like good Hangout fodder for the person that wants to know!) January 19,…